Status:
ENROLLING_BY_INVITATION
Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer, Breast
Health Care Utilization
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This mixed methods study evaluates the effectiveness of an organizational intervention to enhance implementation of strategies to increase breast cancer survivorship symptom and risk management.
Detailed Description
Aim 3 is a hybrid type 1 effectiveness-implementation cluster randomized study with a waitlist control in 26 primary care practices. This study uses a tailored combination of practice facilitation, ex...
Eligibility Criteria
Inclusion
- Self-identification as a staff member or patient who has had breast cancer in a participating practice
Exclusion
- Unable to speak, understand and/or read English
- Unable to provide informed consent
Key Trial Info
Start Date :
June 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
910 Patients enrolled
Trial Details
Trial ID
NCT05400941
Start Date
June 24 2024
End Date
December 31 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers University
New Brunswick, New Jersey, United States, 08901